Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 12 | 15 | 16 | 9 | 4 |
| Income taxes - deferred | 64 | -31 | -130 | 202 | 11 |
| Accounts receivable | 10 | -17 | -21 | 94 | -1 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 278 |
| Other Working Capital | 274 | -51 | -58 | -296 | 385 |
| Other Operating Activity | -1,437 | -1,043 | -999 | -1,470 | -1,431 |
| Operating Cash Flow | $-1,077 | $-1,127 | $-1,193 | $-1,462 | $-753 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -350 | 34 | 0 | 0 | -34 |
| Investing Cash Flow | $-350 | $34 | $N/A | $N/A | $-34 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10 | -13 | -13 | -6 | 0 |
| Common Stock Issued | 264 | 103 | 0 | 1,825 | 1,815 |
| Other Financing Activity | 69 | 380 | 158 | 3,498 | 590 |
| Financing Cash Flow | $323 | $470 | $145 | $5,317 | $2,405 |
| Exchange Rate Effect | -1 | -3 | -11 | 4 | -38 |
| Beginning Cash Position | 7,680 | 8,306 | 9,286 | 5,428 | 3,847 |
| End Cash Position | 6,574 | 7,680 | 8,306 | 9,286 | 5,428 |
| Net Cash Flow | $-1,104 | $-623 | $-969 | $3,855 | $1,618 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,077 | -1,127 | -1,193 | -1,462 | -753 |
| Free Cash Flow | -1,077 | -1,127 | -1,193 | -1,462 | -753 |